Macroview Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23
| Closed | -$589 | – | 116 |
|
|
2024
Q3 | $589 | Hold |
23
| – | – | ﹤0.01% | 531 |
|
|
2024
Q2 | $541 | Hold |
23
| – | – | ﹤0.01% | 533 |
|
|
2024
Q1 | $662 | Sell |
23
-40
| -63% | -$1.15K | ﹤0.01% | 581 |
|
|
2023
Q4 | $2.08K | Hold |
63
| – | – | ﹤0.01% | 523 |
|
|
2023
Q3 | $1.76K | Hold |
63
| – | – | ﹤0.01% | 579 |
|
|
2023
Q2 | $2.16K | Hold |
63
| – | – | ﹤0.01% | 395 |
|
|
2023
Q1 | $1.9K | Hold |
63
| – | – | ﹤0.01% | 362 |
|
|
2022
Q4 | $1.79K | Hold |
63
| – | – | ﹤0.01% | 373 |
|
|
2022
Q3 | $2K | Sell |
63
-34
| -35% | -$1.08K | ﹤0.01% | 332 |
|
|
2022
Q2 | $3K | Hold |
97
| – | – | ﹤0.01% | 333 |
|
|
2022
Q1 | $4K | Buy |
97
+1
| +1% | +$41 | 0.01% | 316 |
|
|
2021
Q4 | $6K | Hold |
96
| – | – | 0.01% | 266 |
|
|
2021
Q3 | $7K | Hold |
96
| – | – | 0.01% | 260 |
|
|
2021
Q2 | $9K | Hold |
96
| – | – | 0.01% | 180 |
|
|
2021
Q1 | $9K | Buy |
96
+23
| +32% | +$2.16K | 0.01% | 157 |
|
|
2020
Q4 | $7K | Buy |
+73
| New | +$7K | 0.01% | 162 |
|